James is a Pediatric Oncology Fellow at Dana-Farber/Boston Children’s Hospital where he currently treats pediatric patients with cancer diagnoses. He completed his MD/PhD at Case Western Reserve University. His graduate work identified enhancer dysregulation as a driver of osteosarcoma metastasis. He joined the Bernstein lab in September 2022 as a research fellow. His work will apply single cell …
Continued
Gary is from Whippany, NJ. He graduated from Amherst College with a B.A. in Neuroscience.
Sonia is a surgeon-scientist interested in understanding gene regulation in cancer.
Alba joined the lab in 2021 as a Sir Henry Wellcome Fellow. Originally from Spain, she undertook her PhD at the University of Oxford before moving to Boston. She is interested in deciphering in the epigenetic mechanisms that lead to tumor development and evolution using single cell technologies.
Interests: Epigenetic circuits in immune cells; High dimensional profiling in tumor microenvironments Zeyu Chen did his undergraduate at Peking University in Beijing, China, studying stem cell genetic engineering in Dr. Hongkui Deng’s lab. He then worked as a research assistant in Dr. Richard Flavell’s lab at Yale for one year, and did his Ph.D. at University …
Continued
Computational and molecular biologist, interested in multidisciplinary approaches to understand gene regulation in healthy cells and during cancer development. Orcid: 0000-0002-6059-0116 https://www.linkedin.com/in/elena-torlai-triglia/ https://elenatt.github.io/cv/
Interests: Cell fate decisions and epigenetic buffering; tissue specific DNA architecture based vulnerabilities to cancer Eli joined the lab in 2020 and is currently studying the role of mitochondrial MDM2 in liposarcoma, both from a wet lab and computational perspective.
Gabriel Griffin earned his undergraduate and medical degrees at Duke University and completed his residency and fellowship training in hematopathology at the Brigham and Women’s Hospital. In his post-doctoral research, Gabe is studying the epigenetic regulation of immune sensitivity in cancer. Gabe is a recipient of the Physician-Scientist Training Award from the Damon Runyon Cancer Research Foundation.
